Philadelphia Pharmaceuticals Company (ASE:PHIL)

ASE:PHIL Statistics

Total Valuation

ASE:PHIL has a market cap or net worth of JOD 12.00 million. The enterprise value is 12.37 million.

Market Cap	12.00M
Enterprise Value	12.37M

Important Dates

The next estimated earnings date is Thursday, February 5, 2026.

Earnings Date	Feb 5, 2026
Ex-Dividend Date	Feb 26, 2025

Share Statistics

ASE:PHIL has 7.50 million shares outstanding.

Current Share Class	7.50M
Shares Outstanding	7.50M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	92.73%
Owned by Institutions (%)	n/a
Float	545,250

Valuation Ratios

The trailing PE ratio is 13.14.

PE Ratio	13.14
Forward PE	n/a
PS Ratio	1.32
PB Ratio	0.91
P/TBV Ratio	0.91
P/FCF Ratio	5.96
P/OCF Ratio	8.86
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.50, with an EV/FCF ratio of 6.14.

EV / Earnings	13.54
EV / Sales	1.36
EV / EBITDA	8.50
EV / EBIT	8.62
EV / FCF	6.14

Financial Position

The company has a current ratio of 3.52, with a Debt / Equity ratio of 0.15.

Current Ratio	3.52
Quick Ratio	2.76
Debt / Equity	0.15
Debt / EBITDA	1.35
Debt / FCF	0.98
Interest Coverage	4.80

Financial Efficiency

Return on equity (ROE) is 7.03% and return on invested capital (ROIC) is 5.96%.

Return on Equity (ROE)	7.03%
Return on Assets (ROA)	5.37%
Return on Invested Capital (ROIC)	5.96%
Return on Capital Employed (ROCE)	10.31%
Revenue Per Employee	70,640
Profits Per Employee	7,080
Employee Count	129
Asset Turnover	0.55
Inventory Turnover	2.52

Taxes

In the past 12 months, ASE:PHIL has paid 243,018 in taxes.

Income Tax	243,018
Effective Tax Rate	21.02%

Stock Price Statistics

The stock price has increased by +6.67% in the last 52 weeks. The beta is -0.00, so ASE:PHIL's price volatility has been lower than the market average.

Beta (5Y)	-0.00
52-Week Price Change	+6.67%
50-Day Moving Average	1.48
200-Day Moving Average	1.42
Relative Strength Index (RSI)	68.88
Average Volume (20 Days)	406

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASE:PHIL had revenue of JOD 9.11 million and earned 913,256 in profits. Earnings per share was 0.12.

Revenue	9.11M
Gross Profit	4.33M
Operating Income	1.43M
Pretax Income	1.16M
Net Income	913,256
EBITDA	1.46M
EBIT	1.43M
Earnings Per Share (EPS)	0.12

Balance Sheet

The company has 1.60 million in cash and 1.97 million in debt, giving a net cash position of -366,992 or -0.05 per share.

Cash & Cash Equivalents	1.60M
Total Debt	1.97M
Net Cash	-366,992
Net Cash Per Share	-0.05
Equity (Book Value)	13.18M
Book Value Per Share	1.76
Working Capital	7.73M

Cash Flow

In the last 12 months, operating cash flow was 1.36 million and capital expenditures 658,802, giving a free cash flow of 2.01 million.

Operating Cash Flow	1.36M
Capital Expenditures	658,802
Free Cash Flow	2.01M
FCF Per Share	0.27

Margins

Gross margin is 47.55%, with operating and profit margins of 15.74% and 10.02%.

Gross Margin	47.55%
Operating Margin	15.74%
Pretax Margin	12.69%
Profit Margin	10.02%
EBITDA Margin	15.97%
EBIT Margin	15.74%
FCF Margin	22.10%

Dividends & Yields

This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 4.38%.

Dividend Per Share	0.07
Dividend Yield	4.38%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	57.49%
Buyback Yield	n/a
Shareholder Yield	4.38%
Earnings Yield	7.61%
FCF Yield	16.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 30, 2016. It was a forward split with a ratio of 1.5.

Last Split Date	May 30, 2016
Split Type	Forward
Split Ratio	1.5

Scores

ASE:PHIL has an Altman Z-Score of 3.56 and a Piotroski F-Score of 7.

Altman Z-Score	3.56
Piotroski F-Score	7